Felix Biotechnology: Funding, Investors & Team (Oct 2026)
Felix Biotechnology is attempting to speed up the arrangement of novel biotherapeutics to oversee irresistible illnesses. Felix Biotechnology's profile therapeutics targets anti-toxin safe microscopic organisms to oversee irresistible sicknesses exactly and really, permitting medical care experts to oversee pressing microbial difficulties in human wellbeing.
Felix Biotechnology has raised $410k across 2 funding rounds on record, the most recent a Grant of $310k announced in Jul 2022.
That round is below the $8.4M median round size for Biotechnology companies tracked on FundedIQ over the last two years.
Felix Biotechnology Company Profile and Key Stats
Latest funding round on record: Jul 2022.
Felix Biotechnology Funding Rounds
Felix Biotechnology raised $100k in a Grant announced in Mar 2022.
4 months later, a Grant of $310k was announced in Jul 2022.
Felix Biotechnology Founders and Leadership Team
No contact details are on record for this team yet.
Felix Biotechnology Funding Compared to Other Biotechnology Startups
Felix Biotechnology's latest round of $310k is below the median round in Biotechnology. Medians cover the last 24 months of disclosed rounds.
Funded Startups Like Felix Biotechnology in Biotechnology and San Francisco
Companies Similar to Felix Biotechnology
Prolific Machines is a biotech company located in San Francisco, California, that was established in 2020. It…
Altay Therapeutics is a biotech company focused on finding and discovering small molecule therapies for…
Kallyope, we believe that the gut is the gateway to our internal world. Containing millions of neurons, the…
Astrocyte Pharmaceuticals is a drug development company that helps in the recovery and well-being of brain…
Tiny Health offers a gut health test specifically designed for mothers and babies aged 0 to 3 years.…
Junevity is dedicated to using cutting-edge transcription factor medicines to combat age-related diseases.…
Arkea Bio creates technology aimed at reducing greenhouse gas (GHG) emissions in the agricultural sector.
Serán is a contract development and manufacturing organization providing a comprehensive suite of…
Precision’s goal is to provide breakthrough treatments for the one billion patients worldwide suffering from…
Enveda is a biotechnology company that utilizes AI-powered tools to explore and characterize molecules from…
Avery Therapeutics, Inc. is a company dedicated to developing tissue engineered therapeutics to treat…
Felix Biotechnology Funding FAQs
What does Felix Biotechnology do?
Felix Biotechnology is attempting to speed up the arrangement of novel biotherapeutics to oversee irresistible illnesses. Felix Biotechnology's profile therapeutics targets anti-toxin safe microscopic organisms to oversee irresistible sicknesses exactly and really, permitting medical care experts to oversee pressing microbial difficulties in human wellbeing.
How much funding has Felix Biotechnology raised?
Felix Biotechnology has raised $410k across 2 rounds on record. The most recent is a Grant of $310k announced in Jul 2022.
When did Felix Biotechnology last raise funding?
Felix Biotechnology's most recent funding round on record is a Grant of $310k, announced in Jul 2022.
Who founded Felix Biotechnology?
FundedIQ lists Paul Turner (Founder) at Felix Biotechnology.
Who is the CEO of Felix Biotechnology?
Robert McBride is listed as CEO at Felix Biotechnology.
Where is Felix Biotechnology headquartered?
Felix Biotechnology is based in San Francisco, California, United States.
How many employees does Felix Biotechnology have?
Felix Biotechnology is in the 1-10 employee band.
How does Felix Biotechnology's funding compare to other Biotechnology startups?
Felix Biotechnology's latest round of $310k is below the $8.4M median round size for Biotechnology companies on FundedIQ across 4,185 tracked companies over the last two years.
About FundedIQ's Felix Biotechnology Funding Data
FundedIQ tracks announced funding rounds and refreshes this profile every week. Round dates, stages and amounts are normalised to a single format, converted to US dollars, and de-duplicated: two records of the same round announced days apart are merged, and two genuinely different rounds are kept apart on the amounts they disclose. Amounts shown are the disclosed figures only — a round announced without a number is listed and excluded from the total rather than estimated.
Employee counts are reported bands, not exact headcounts. Founder and executive names carry the job title on record. Anything we do not hold for Felix Biotechnology is left off this page rather than filled in.
Know who just raised. Then know who to reach.
Startup funding intelligence on every funded startup: the round, the investors and the founders, as a file in your inbox or searchable in the app.
Radar from $49/mo · Pro from $149/mo. Card required, nothing charged until day 15, and we email you 3 days before that. Need something specific? Custom plans from $499/mo.